NCT00121355

Novofine Autocover Safety Needle Versus BD Safety Glide

An Open-Label, Multi-Center, Prospective Cross-Over Study of Preference and Safety of NovoFine® Autocover(TM) Needles Compared to BD Safety Glide (TM) Syringes in the Hospital Setting

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 83 (actual)
• Sponsor: Novo Nordisk A/S · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This trial is conducted in the United States of America (USA). The aim of this trial is to examine whether nurses prefer to use the NovoFine® Autocover Needle or the BD Safety Glide (TM) Syringe (only) in a hospital setting. The number of needle stick injuries will also be evaluated and whether these hospital nurses prefer the safety features of the NovoFine® Autocover Needle versus those of the BD Safety Glide (TM) Syringe. The identified hospital nurses will evaluate the two types of needles during standard administration of insulin to patients being treated for diabetes.

Conditions

• Diabetes
• Healthcare Professionals
• Delivery Systems

Interventions

Type	Name	Description
DEVICE	safety glide
DEVICE	autocover needle

Timeline

• Start date: 2005-07-01
• Primary completion: 2006-06-01
• Completion: 2006-06-01
• First posted: 2005-07-21
• Last updated: 2016-10-18

Locations

1 site across 1 country: United States